Senti Biosciences Inc (SNTI) saw an uptrend of 23.81% in the recent trading with $2.08 being its most recent. The current price level -87.72% lower than the highest price of $16.94 marked by the stock while trading over the past 52-weeks, whereas it is 65.08% higher than the lowest price of $1.26 the company dropped to over past 52-weeks. The latest news story on SNTI appeared in (GlobeNewswire) under the title “Senti Bio to Present at BioJapan”.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
Senti Biosciences Inc Earnings – What Happened With SNTI
Coming around sales and income figures on SNTI Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
SNTI – Senti Biosciences Inc Stock Earnings Estimates
Company’s EPS for the last quarter was -6.31.
Senti Biosciences Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 26.16 million. SNTI does have institutional investors; and they hold 10.36% of the stock.
As on 2024-06-30, NEA MANAGEMENT COMPANY, LLC was the top most holder in Senti Biosciences Inc (NASDAQ:SNTI) with an ownership of 4.43 million shares of the company or 9.6834 of the stake worth $1.22 million. The filing also reveals 8VC GP I, LLC as the second largest holder in the company with a control over 5.5516 of the outstanding shares. Its stake is worth $7.0 million for having 2.54 million shares in hand.
ARK INVESTMENT MANAGEMENT LLC also came holding a key position in the company during the recent quarter and it now holds 3.4693 of the outstanding shares. With this there are now 17.0 institutions which have possession in SNTI’s shares.
Key Metrics for SNTI
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Senti Biosciences Inc has a debt to equity ratio of 1.27.
